Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis. - Yang, Shuo; Hou, Yibing; Wang, Xiaohui; Kang, Shuo; Pan, Zhenhua (PLoS ONE, 2026)